Autonomix (AMIX) Medical announced the United States Patent and Trademark Office has issued U.S. patent 12,064,256 titled, Systems and Methods for Treating Cancer and/or Augmenting Organ Function.

"Reliability and performance are at the core of our E-Motion™ powertrain systems," said Xavier Montagne, Chief Technology Officer at Vision Marine. "This patent application demonstrates the benefits ...

SaverOne 2014 (SVRE) announced the award by the United States Patent and Trademark Office of a new patent. The patent, bearing the number 12,174,309 and issued on December 24, 2024, is entitled ...

FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility ...

Vision Marine Technologies Inc. (the Company, Vision Marine, we, us, our) (Nasdaq:VMAR ) is pleased to announce the filing of its latest p ...

Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq ... of a national phase patent application by the United States Patent and Trademark Office (“USPTO”).

CellTrust today reaffirms the company received Ex Parte Reexamination Certificates from the U.S. Patent and Trademark Office ...

Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...

of the U.S. Patent and Trademark Office for Inter Partes Review (IPR) of U.S. patents asserted by Applied Optoelectronics, ...

2025 / Vision Marine Technologies Inc. (the "Company," "Vision Marine," "we," "us," "our") (Nasdaq:VMAR) is pleased to announce the filing of its latest patent application with the United States ...

MONTRÉAL, QC / ACCESS Newswire / January 27, 2025 / Vision Marine Technologies Inc. (the "Company," "Vision Marine," "we," "us," "our") (NASDAQ:VMAR) is pleased to ...